Andreas Poschenrieder

962 total citations
13 papers, 732 citations indexed

About

Andreas Poschenrieder is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andreas Poschenrieder has authored 13 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andreas Poschenrieder's work include Chemokine receptors and signaling (5 papers), Peptidase Inhibition and Analysis (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Andreas Poschenrieder is often cited by papers focused on Chemokine receptors and signaling (5 papers), Peptidase Inhibition and Analysis (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Andreas Poschenrieder collaborates with scholars based in Germany, United States and France. Andreas Poschenrieder's co-authors include Julie A. Stenken, Margret Schottelius, Hans‐Jürgen Wester, Markus Schwaiger, Theresa Osl, Ulrich Keller, Michael Laßmann, Andreas K. Buck, Andreas Schirbel and Heribert Hänscheid and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Analytica Chimica Acta.

In The Last Decade

Andreas Poschenrieder

13 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Poschenrieder Germany 10 319 216 178 167 97 13 732
Biying Xu United States 14 195 0.6× 114 0.5× 137 0.8× 243 1.5× 192 2.0× 29 708
Robert M. Conway Australia 18 276 0.9× 216 1.0× 226 1.3× 75 0.4× 54 0.6× 69 997
Giuliana Anna Porro Italy 15 184 0.6× 199 0.9× 325 1.8× 202 1.2× 36 0.4× 22 867
A Ríos United States 8 495 1.6× 62 0.3× 170 1.0× 210 1.3× 45 0.5× 14 1.2k
Wenhao Zhang China 16 391 1.2× 46 0.2× 288 1.6× 298 1.8× 54 0.6× 88 898
Kathy Nguyen United States 10 115 0.4× 243 1.1× 171 1.0× 323 1.9× 35 0.4× 22 819
Christiane Geyer Germany 11 119 0.4× 81 0.4× 233 1.3× 125 0.7× 93 1.0× 32 695
Dennis Doleschel Germany 11 169 0.5× 101 0.5× 148 0.8× 100 0.6× 257 2.6× 17 678
Carola Heneweer Germany 18 257 0.8× 167 0.8× 276 1.6× 210 1.3× 257 2.6× 35 1.1k
Qiang Zhou China 15 152 0.5× 162 0.8× 133 0.7× 126 0.8× 285 2.9× 54 736

Countries citing papers authored by Andreas Poschenrieder

Since Specialization
Citations

This map shows the geographic impact of Andreas Poschenrieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Poschenrieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Poschenrieder more than expected).

Fields of papers citing papers by Andreas Poschenrieder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Poschenrieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Poschenrieder. The network helps show where Andreas Poschenrieder may publish in the future.

Co-authorship network of co-authors of Andreas Poschenrieder

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Poschenrieder. A scholar is included among the top collaborators of Andreas Poschenrieder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Poschenrieder. Andreas Poschenrieder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lorenz, Georg, Joana Cardoso, Maciej Lech, et al.. (2022). A randomized prospective cross over study on the effects of medium cut-off membranes on T cellular and serologic immune phenotypes in hemodialysis. Scientific Reports. 12(1). 16419–16419. 4 indexed citations
2.
Morgans, Alicia K., R. Lehmann, Axel Heidenreich, et al.. (2022). Identifying patient profiles and mapping the patient journey across three countries in a large-scale, fully digital survey of patients with prostate cancer.. Journal of Clinical Oncology. 40(6_suppl). 16–16. 1 indexed citations
3.
Poschenrieder, Andreas, Markus Thaler, Ralf Junker, & Peter B. Luppa. (2019). Recent advances in immunodiagnostics based on biosensor technologies—from central laboratory to the point of care. Analytical and Bioanalytical Chemistry. 411(29). 7607–7621. 28 indexed citations
4.
Schottelius, Margret, Theresa Osl, Andreas Poschenrieder, et al.. (2017). [177Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent. Theranostics. 7(9). 2350–2362. 90 indexed citations
5.
Poschenrieder, Andreas, Margret Schottelius, Theresa Osl, Markus Schwaiger, & Hans‐Jürgen Wester. (2017). [64Cu]NOTA-pentixather enables high resolution PET imaging of CXCR4 expression in a preclinical lymphoma model. EJNMMI Radiopharmacy and Chemistry. 2(1). 2–2. 9 indexed citations
6.
Poschenrieder, Andreas, Margret Schottelius, Markus Schwaiger, Horst Kessler, & Hans‐Jürgen Wester. (2016). The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity. EJNMMI Research. 6(1). 36–36. 32 indexed citations
7.
Poschenrieder, Andreas, Theresa Osl, Margret Schottelius, et al.. (2016). First 18F-Labeled Pentixafor-Based Imaging Agent for PET Imaging of CXCR4 Expression In Vivo. Tomography. 2(2). 85–93. 26 indexed citations
8.
Hyafil, Fabien, Jaroslav Pelisek, Iina Laitinen, et al.. (2016). Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer 68Ga-Pentixafor for PET. Journal of Nuclear Medicine. 58(3). 499–506. 87 indexed citations
9.
Poschenrieder, Andreas, Margret Schottelius, Markus Schwaiger, & Hans‐Jürgen Wester. (2016). Preclinical evaluation of [68Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo — a comparison to [68Ga]pentixafor. EJNMMI Research. 6(1). 70–70. 19 indexed citations
10.
Herrmann, Ken, Margret Schottelius, Constantin Lapa, et al.. (2015). First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease. Journal of Nuclear Medicine. 57(2). 248–251. 188 indexed citations
11.
Lapa, Constantin, Stefan Knop, Andreas Schirbel, et al.. (2015). First in man experience of CXCR4-directed endoradiotherapy with 177Lu- and 90Y-labelled Pentixather in multiple myeloma patients. 56. 14–14. 3 indexed citations
12.
Schottelius, Margret, Matthias Konrad, Theresa Osl, Andreas Poschenrieder, & Hans‐Jürgen Wester. (2015). An optimized strategy for the mild and efficient solution phase iodination of tyrosine residues in bioactive peptides. Tetrahedron Letters. 56(47). 6602–6605. 10 indexed citations
13.
Stenken, Julie A. & Andreas Poschenrieder. (2014). Bioanalytical chemistry of cytokines – A review. Analytica Chimica Acta. 853. 95–115. 235 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026